China Medical System Holdings Limited 2022 ESG Report

The report details the company's seventh Environmental, Social and Governance (ESG) Report, covering the fiscal year 2022. It highlights the company's commitment to sustainable development, including innovative drug incubation, green development, employee diversity, and community engagement. The report also emphasizes the company's dedication to ethical business practices, compliant operations, and product quality assurance. It includes a materiality assessment, highlighting key ESG concerns, and outlines the company's goals and progress across various ESG aspects, such as healthcare accessibility, talent absorption, environmental protection, and climate change response.